Nonemergent Percutaneous Coronary Intervention on an Unprotected Left Main Coronary Artery Supported with Impella® Heart Pump in Patients Ineligible for Surgical Revascularization.
Perwaiz M MerajSimon DixonJeffery MosesKarim IbrahimAndreas SchäferIbrahim AkinJonathan HillTheodore SchreiberWilliam W O'NeillPublished in: Journal of interventional cardiology (2019)
The results of our study suggest that prophylactic Impella support appears to mitigate the risks inherent to surgical ineligibility in patients undergoing a nonemergent ULMCA PCI. Our results require further investigation.
Keyphrases
- percutaneous coronary intervention
- coronary artery
- patients undergoing
- acute coronary syndrome
- acute myocardial infarction
- st segment elevation myocardial infarction
- coronary artery disease
- end stage renal disease
- coronary artery bypass grafting
- antiplatelet therapy
- st elevation myocardial infarction
- atrial fibrillation
- ejection fraction
- newly diagnosed
- chronic kidney disease
- extracorporeal membrane oxygenation
- heart failure
- patient reported outcomes
- risk assessment
- left ventricular
- human health
- left ventricular assist device
- pulmonary hypertension